SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.
Viruses evade the innate immune response by suppressing the production or activity of cytokines such as type I interferons (IFNs). Here we report the discovery of a mechanism by which the SARS-CoV-2 virus coopts an intrinsic cellular machinery to suppress the production of the key immunostimulatory cytokine IFN-?. We reveal ... that the SARS-CoV-2 encoded nonstructural protein 2 (NSP2) directly interacts with the cellular GIGYF2 protein. This interaction enhances the binding of GIGYF2 to the mRNA cap-binding protein 4EHP, thereby repressing the translation of the Ifnb1 mRNA. Depletion of GIGYF2 or 4EHP significantly enhances IFN-? production, which inhibits SARS-CoV-2 replication. Our findings reveal a target for rescuing the antiviral innate immune response to SARS-CoV-2 and other RNA viruses.
Mesh Terms:
COVID-19, Carrier Proteins, Cell Line, Eukaryotic Initiation Factor-4E, Humans, Immunity, Innate, Interferon Type I, Protein Biosynthesis, RNA, Messenger, SARS-CoV-2, Viral Nonstructural Proteins, Virus Replication
COVID-19, Carrier Proteins, Cell Line, Eukaryotic Initiation Factor-4E, Humans, Immunity, Innate, Interferon Type I, Protein Biosynthesis, RNA, Messenger, SARS-CoV-2, Viral Nonstructural Proteins, Virus Replication
Proc Natl Acad Sci U S A
Date: Aug. 09, 2022
PubMed ID: 35878012
View in: Pubmed Google Scholar
Download Curated Data For This Publication
244201
Switch View:
- Interactions 4